Drug intelligence / Profile preview

umbilical cord blood stem cell

Development stage: Unknown
Lead developer: Shiyan Taihe Hospital
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intravenous, Intrathecal

Overview

Umbilical cord blood stem cells, specifically human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) and mononuclear cells (UCB-MNCs), are being investigated by Taihe Hospital of Shiyan for the treatment of ischemic stroke and related cerebrovascular diseases. These cell therapies are designed to address the complex pathophysiology of cerebral infarction by providing neuroprotection and promoting tissue regeneration. The primary mechanism of action involves the paracrine secretion of various growth factors and cytokines, such as brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor (VEGF), which support neuronal survival, stimulate angiogenesis, and modulate the post-ischemic inflammatory response. Clinical trials at Taihe Hospital have explored the safety and efficacy of these cells when administered intravenously or intrathecally to patients in the acute or subacute phases of stroke.

Other names: hUCB-MSCsUCB-MSCshuman umbilical cord blood mesenchymal stem cellsumbilical cord blood mononuclear cellsUCB-MNCs

Beyond the preview

Go deeper on umbilical cord blood stem cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on umbilical cord blood stem cell.

Explore the full profile